Daclatasvir, sofosbuvir, and ribavirin combination for HCV patients with advanced cirrhosis or posttransplant recurrence: Phase 3 ALLY-1 study, in The European Association for the Study of the Liver (EASL) 50th Annual Meeting 2015 - Poordad, F
et al.